Correlation Between Day One and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Seres Therapeutics, you can compare the effects of market volatilities on Day One and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Seres Therapeutics.
Diversification Opportunities for Day One and Seres Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Day and Seres is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Day One i.e., Day One and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Day One and Seres Therapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 2.85 times less risky than Seres Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 70.00 in Seres Therapeutics on August 29, 2024 and sell it today you would earn a total of 22.00 from holding Seres Therapeutics or generate 31.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Seres Therapeutics
Performance |
| Timeline |
| Day One Biopharmaceu |
| Seres Therapeutics |
Day One and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Seres Therapeutics
The main advantage of trading using opposite Day One and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |